P078 (0062) TWO DISTINCT PROGNOSTIC GROUPS IN ADVANCED-STAGE HODGKIN LYMPHOMA REVEALED BY THE PRESENCE AND SITE OF BULKY DISEASE

P078 (0062) TWO DISTINCT PROGNOSTIC GROUPS IN ADVANCED-STAGE HODGKIN LYMPHOMA REVEALED BY THE PRESENCE AND SITE OF BULKY DISEASE

Bibliographic Details
Format:	Article
Language:	English
Published:	Wiley 2018-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000547923.79082.93

Similar Items

P078: Predicting the Health-Related Quality of Life of Hodgkin Lymphoma Survivors: Identification of Risk Factors
by: Nele Stadtbaeumer, et al.
Published: (2022-10-01)

Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma
by: Claire Lamaison, et al.
Published: (2022-10-01)

Metabolic tumor parameters complement clinicopathological factors in prognosticating advanced stage Hodgkin Lymphoma
by: Ashish Mohite, et al.
Published: (2023-06-01)

The Bulky mass in diffuse large B Cell Lymphoma: Prognostic impact? A treatment guiding factor?
by: Masrour, et al.
Published: (2023-01-01)

Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors
by: Theodoros P. Vassilakopoulos, et al.
Published: (2022-07-01)

Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma
by: Alexandra Papoudou-bai, et al.
Published: (2018-11-01)

P1093: A NEW PROGNOSTIC MODEL FOR INDIVIDUAL OUTCOME PREDICTION IN ADVANCED-STAGE HODGKIN LYMPHOMA.
by: R. Rask Kragh Jørgensen, et al.
Published: (2022-06-01)

Evaluation of the Prognostic Importance of c-Myc and Bcl-2 Expressions and the Presence of Epstein-Barr Virus in Classical Hodgkin Lymphoma
by: Aydan KILIÇARSLAN, et al.
Published: (2018-09-01)

Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
by: Arina Martynchyk, et al.
Published: (2023-10-01)

Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma
by: Özgür Ömür, et al.
Published: (2014-03-01)

Determination of Hodgkin and non-Hodgkin lymphoma stage with combined positron-emission and computed tomography
by: I. V. Boikov, et al.
Published: (2011-12-01)

P094: Long-term outcomes of bulky classic Hodgkin lymphoma managed with a PET-adapted approach demonstrate excellent outcomes in PET-negative cases
by: Jowon Laura Kim, et al.
Published: (2022-10-01)

Definition of bulky disease in early stage diffuse large B-cell lymphoma in computed tomography on coronal and transverse planes
by: Mohammad Ma’koseh, et al.
Published: (2023-11-01)

Using Machine Learning to Expand the Ann Arbor Staging System for Hodgkin and Non-Hodgkin Lymphoma
by: Huan Wang, et al.
Published: (2023-07-01)

Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications
by: Vasileios Georgoulis, et al.
Published: (2023-06-01)

Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
by: Fatemeh Javanmardi, et al.
Published: (2018-01-01)

Prognostic significance of elevated D-dimer level in classical Hodgkin's Lymphoma
by: Waseem F Al-Tameemi, et al.
Published: (2023-01-01)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
by: Akram Al-Ibraheem, et al.
Published: (2022-10-01)

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma
by: Andreas Engert, et al.
Published: (2017-12-01)

Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma
by: Hélène Vellemans, et al.
Published: (2021-07-01)

PB2435: ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOMES IN HODGKIN LYMPHOMA: A PROGNOSTIC STUDY OF 30 PATIENTS WITH RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
by: Shayan Zamani, et al.
Published: (2023-08-01)

Macrophages in Hodgkin's lymphoma.
by: Pazianas, M
Published: (2010)

The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites.
by: Newton, R, et al.
Published: (1997)

Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques
by: Elisabetta Maria Abenavoli, et al.
Published: (2023-03-01)

Safety, pharmacokinetics, and pharmacodynamics in healthy Chinese volunteers treated with SC0062, a highly selective endothelin‐A receptor antagonist
by: Yun Liu, et al.
Published: (2024-03-01)

Prognostic Role of the Red Blood Cell Distribution Width (RDW) in Hodgkin Lymphoma
by: Ines Herraez, et al.
Published: (2020-11-01)

MASSIVE TUMOR BURDEN IN HODGKIN’S LYMPHOMA AS A PROGNOSTIC FACTOR IN YOUNG ADULTS
by: A. P. Karitsky
Published: (2016-02-01)

Clinical Features and Prognostic Factors of Hodgkin’s Lymphoma: A Single Center Experience
by: Saadettin Kılıçkap, et al.
Published: (2013-06-01)

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
by: Alvaro, T, et al.
Published: (2005)

Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group
by: Aznar, M, et al.
Published: (2017)

P024 (0009) LIMITED-STAGE HODGKIN LYMPHOMA: MINIMIZING TOXICITY
Published: (2018-10-01)

P012 (0081) SOLUBLE CYTOKINES IN HODGKIN LYMPHOMA PATIENTS TREATED WITH A GHSG POLICY: AN ANALYSIS OF THE CZECH HODGKIN LYMPHOMA STUDY GROUP
Published: (2018-10-01)

P039: HLA expression status and prognostic impact of B-cell content in patients with early-stage unfavorable Hodgkin lymphoma
by: Johanna Grund, et al.
Published: (2022-10-01)

Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-hodgkins Lymphoma
by: Salemi, M, et al.
Published: (2009)

Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma.
by: Salemi, M, et al.
Published: (2009)

Non-Hodgkin Lymphoma Secondary to Hodgkin Lymphoma in an Adult Patient With Nijmegen Breakage Syndrome
by: Krischan Braitsch, et al.
Published: (2018-10-01)

Macrophages in Hodgkin's lymphoma [2]
by: Pazianas, M
Published: (2010)

Relapsed/Refractory Hodgkin Lymphoma
by: Semira Sheikh, et al.
Published: (2018-06-01)

Genetics of classical Hodgkin Lymphoma
by: Gianluca Schiavoni, et al.
Published: (2018-06-01)

The Treatment of Non-Hodgkin's Lymphomas
by: David J. Straus
Published: (2023-08-01)